Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...

On the bar graph on the right hand side ... We did do it, as you said, to validate the delivery of an incretin and be able to show PD effect as well, which we were able to do both of those ...

They then tested these peptides in the neuronal Neuroscreen-1 (NS-1) cell line and the β-cell line INS1 to investigate their biological effects, focusing on their ability to induce Fos ...

Incretin-based drugs are a class of medications used to manage type 2 diabetes. These drugs mimic or enhance the effects of incretins, which are hormones that stimulate insulin release from the ...

Ahead of Sunday’s Season 1 finale, Adult Swim has renewed Common Side Effects for a second season. The animated comedic thriller series from co-creators Joe Bennett (Scavengers Reign ...

Rani Therapeutics Holdings Inc. (RANI) reported its financial results for the fourth quarter of 2024, revealing a slightly larger-than-expected loss per share. The company posted an actual EPS of ...

The effect of saccharin on the microbiome has received much attention, but its impact on pathogenic bacterial species is less ...

Rani Therapeutics Holdings Inc. (RANI) reported its financial results for the fourth quarter of 2024, revealing a slightly larger-than-expected loss per share. The company posted an actual EPS of ...

Common Side Effects is, to be very forthright, the best work of sociopolitical commentary since Sean Baker's masterpiece Red Rocket — still the defining Trump-era movie — and Jordan Peele's Nope.

Many individuals are told that managing type 2 diabetes is simply a matter of controlling blood sugar. As long as glucos ...